Medtech Insight - News And Expert Analysis For Medtech Decision Makers since 1975

Women’s health investment could exceed $600bn by 2030 as high-burden conditions like heart disease, Alzheimer’s, digital health and menopause are expected to draw more interest from investors.

A new report from the Wound Care Sector Working Group sounds the alarm: chronic wound care is rapidly becoming a growing burden. The EU must act now to make care coordination, reimbursement and innovation strategic priorities.

AI-enabled tools deliver faster radiology reads, clinical decision-support, personalized treatment insights and continuous patient monitoring, but a new report from Firefinch Software and IMed Consultancy advises device developers how to enter and stay in this rapidly growing market.

Boston Scientific's Watchman FLX matched blood thinners for stroke prevention and outperformed them on bleeding in the CHAMPION-AF trial. The 3,000-patient trial met every endpoint – and Boston Scientific is now moving to expand the device's indication and Medicare coverage.

Browne Jacobson partner Gerard Hanratty spoke at BioWales 2026 to give a legal firm’s perspective on how the UK should evolve its medtech regulatory system, pursue global harmonization and take opportunities to embed best practice AI.

Payers' and patients' growing preference for outpatient care is increasing pressure on private providers to continually reassess how they deliver value. Jean-Philippe Grosmaitre and Guillaume Duparc, partners at L.E.K. Consulting, outlined growth opportunities available to private hospitals.